These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34712946)

  • 1. A Case Report of a Rare Heterozygous Variant in the
    Oka H; Nakau K; Imanishi R; Furukawa T; Tanabe Y; Hirono K; Hata Y; Nishida N; Azuma H
    CJC Open; 2021 Sep; 3(9):1195-1198. PubMed ID: 34712946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of adolescent myofibrillar myopathy due to a
    Xiao H; Song L; Tao L
    Heliyon; 2024 Feb; 10(3):e25009. PubMed ID: 38314304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Survival Following Cardiac Arrest Without Implantable Defibrillator Protection in a Hypertrophic Cardiomyopathy Patient.
    Cetin M; Ucar O; Canbay A; Cetin ZG; Cicekcioglu H; Diker E
    Cardiol Res; 2011 Jun; 2(3):132-135. PubMed ID: 28352382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left Bundle Pacing for Left Bundle Branch Block and Intermittent Third-Degree Atrioventricular Block in a
    Zhang L; Cheng X; Chen J; Zhou M; Qian T; Zhang Z; Yin J; Zhang H; Dai G; Qin Y; Yang S
    Front Pediatr; 2020; 8():312. PubMed ID: 32612965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel compound heterozygous variant in
    Li T; Jin Y; Liu R; Hua Y; Zhou K; Luo S; Li Y; Zhang D
    Front Cardiovasc Med; 2023; 10():1212417. PubMed ID: 37396576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of novel alpha-helical rod domain desmin (DES) pathogenic variants associated with dilated cardiomyopathy, atrioventricular block and a risk for sudden cardiac death.
    Fischer B; Dittmann S; Brodehl A; Unger A; Stallmeyer B; Paul M; Seebohm G; Kayser A; Peischard S; Linke WA; Milting H; Schulze-Bahr E
    Int J Cardiol; 2021 Apr; 329():167-174. PubMed ID: 33373648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Hypertrophic cardiomyopathy with recurrent episodes of ventricular fibrillation and concurrent sinus arrest.
    Hamidi J; Winter J; Weber R; Dittmann S; Schulze-Bahr E
    Front Cardiovasc Med; 2023; 10():1240189. PubMed ID: 38028454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
    Nazer B; Dale Z; Carrassa G; Reza N; Ustunkaya T; Papoutsidakis N; Gray A; Howell SJ; Elman MR; Pieragnoli P; Ricciardi G; Jacoby D; Frankel DS; Owens A; Olivotto I; Heitner SB
    Heart Rhythm; 2020 Jul; 17(7):1107-1114. PubMed ID: 32084597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator.
    Primo J; Geelen P; Brugada J; Filho AL; Mont L; Wellens F; Valentino M; Brugada P
    J Am Coll Cardiol; 1998 Apr; 31(5):1081-5. PubMed ID: 9562010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
    Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
    Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthesia in a Child with Newly Diagnosed Hypertrophic Cardiomyopathy for Placement of Implantable Cardioverter Defibrillator.
    Kumar R; Kumari B
    Anesth Essays Res; 2018; 12(1):271-272. PubMed ID: 29628595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden Cardiac Arrest in a Patient With Apical Hypertrophic Cardiomyopathy: Case Report and a Brief Review of Literature.
    Gupta T; Paul N; Palaniswamy C; Balasubramaniyam N; Aronow WS; Kolte D; Khera S; Shah AB; Gass A
    Am J Ther; 2016; 23(1):e276-82. PubMed ID: 25923227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].
    Maron BJ; Spirito P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):297-302. PubMed ID: 19791462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
    Yazaki K; Suzuki A; Shiga T; Minami Y; Arai K; Ashihara K; Shoda M; Hagiwara N
    BMC Cardiovasc Disord; 2021 Feb; 21(1):106. PubMed ID: 33607967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.